Adaptin Bio (APTN) Prepaid Assets (2024 - 2026)
Adaptin Bio's (APTN) quarterly Prepaid Assets came in at $310964.0 in Q2 2026, little changed year-over-year from $311116.0 in Q2 2025, and down 23.18% quarter-over-quarter from $404808.0 in Q1 2026.
Analysis
Adaptin Bio (APTN) Prepaid Assets (2024 - 2026) Analysis & Trends
Adaptin Bio has disclosed Prepaid Assets across 3 years of filings, most recently posting $310964.0 for Q2 2026.
- In Q2 2026, Prepaid Assets changed 0.05% year-over-year to $310964.0; the TTM figure through Jun 2026 stood at $310964.0 (changed 0.05% YoY), while the FY2025 annual figure was $159985.0, up 1296.76% from the prior year.
- Prepaid Assets came in at $310964.0 for Q2 2026 at Adaptin Bio, down from $404808.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $479775.0 in Q1 2025 to a low of $11454.0 in Q4 2024.
- Average Prepaid Assets over 3 years is $296926.7, with a median of $311116.0 recorded in 2025.
- Year-over-year, Prepaid Assets jumped 1296.76% in 2025 and decreased 15.63% in 2026.
- Over 3 years, Prepaid Assets stood at $11454.0 in 2024, then jumped by 1296.76% to $159985.0 in 2025, then surged by 94.37% to $310964.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $310964.0 in Q2 2026, $404808.0 in Q1 2026, and $159985.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 310,964.00 |
| Mar 31, 2026 | 404,808.00 |
| Dec 31, 2025 | 159,985.00 |
| Sep 30, 2025 | 400,385.00 |
| Jun 30, 2025 | 311,116.00 |
| Mar 31, 2025 | 479,775.00 |
| Dec 31, 2024 | 11,454.00 |